Instrumento Inactivo

Otros idiomas Elekta AB (publ) Other OTC

Acciones

EKTAY

US28617Y1010

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Elekta : launches AI-powered, adaptive CT-Linac for next level cancer care	03/05
Elekta to Buy Philips Healthcare's Treatment Planning Patent Portfolio	03/05
Elekta : further strengthens its Elekta ONE software suite with acquisition of Philips treatment planning patent portfolio	03/05
Elekta, GE HealthCare Team Up for New Cancer Treatment Planning Services	22/04
Elekta and MIM Software Inc. Announce Collaboration to Combine Best-Of-Breed Solutions for Advanced Treatment Planning in the Delivery of Radiation Therapy	22/04
Elekta : Invitation to investor meeting at ESTRO 2024 in Glasgow	28/03
ELEKTA : Elekta’s attractiveness reinforced	06/03
Elekta announces resignation of Board Member Kelly Londy	01/03
Elekta AB Announces Resignation of Kelly Londy, Member of the Board	01/03
ELEKTA : Q3 miss; mid-to-longer term prospects remain promising	01/03
Elekta AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	29/02
L'ETF della settimana: una strategia basata sul vantaggio competitivo	19/01
ETF der Woche: Eine Strategie, die auf Wettbewerbsvorteile setzt	19/01
ETF van de week: inzetten op concurrentievoordelen	18/01
ETF de la semaine : Une stratégie qui mise sur les avantages concurrentiels	18/01
Nordic Stocks Closed Down Wednesday; Sinch Took Biggest Hit	03/01
Nordic Shares Decreased Tuesday; Sinch Took Biggest Hit	02/01
Elekta and Bristol Myers Squibb Partner on Digital Solution for Patients with Melanoma	19/12
Elekta, Bristol Myers Squibb Collaborate on Digital Platform for Melanoma Patients	19/12
Nordic Shares Closed Up Thursday; Autostore Holdings Topped Leaders	30/11

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Titulares

ELEKTA : Elektas refuerza su atractivo

06 de marzo 2024 a las 17:06